ARK Sells Amazon, Buys CoreWeave and Twist Bioscience

Cathie Wood's ARK Invest sold Amazon shares while buying CoreWeave and Twist Bioscience in its daily trades on November 12, 2026. The moves reflect a shift toward AI infrastructure and biotech. ARK purchased 283,022 CoreWeave shares worth $17.2 million and 72,834 Twist Bioscience shares for $8.9 million. It sold 15,941 Amazon shares valued at $4.2 million, continuing a recent trend of reducing exposure to the e-commerce giant. Other notable trades included selling Palantir and Tempus AI shares while buying Archer Aviation, Kratos Defense, Rocket Lab, and Scribe Therapeutics. ARK also continued offloading BYD shares throughout the week.